Đang chuẩn bị liên kết để tải về tài liệu:
PD-L1 expressing circulating tumour cells in head and neck cancers

Blockade of the PD-1/PD-L1 immune checkpoint pathway is emerging as a promising immunotherapeutic approach for the management and treatment of head and neck cancer patients who do not respond to 1st/2nd line therapy. | PD-L1 expressing circulating tumour cells in head and neck cancers